MenoGeniX is currently seeking partnership opportunities and further funding for additional clinical trials leading to FDA approval and commercialization of MNGX-100 to treat hot flashes in symptomatic individuals. Potential partners, licensors and acquirers of interest include innovator, biosimilar and women's healthcare companies. For more information about potential partnerships and funding opportunities with MenoGeniX, contact our business development team at